Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GluePloid: EmbryoGlue in Euploid Blastocyst Transfers
NCT06165367Recruiting
- Sponsor
- ART Fertility Clinics
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of EmbryoGlue in infertility (2 arms), sponsored by ART Fertility Clinics. Primary endpoint: Live birth rate at 41 weeks. Started Jan 2024; status: recruiting.
02
Drugs
EmbryoGlue
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06165367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06165367.